Blog
Featured post
Truveta Data now includes more than 120 million de-identified patients
Truveta has also partnered with more than 100 organizations across life sciences, healthcare, public health, academic research organizations, and others to use regulatory-grade EHR data enabling scientifically rigorous research.
Truveta community expands to more than 50 organizations
Truveta announced today that it is partnering with more than 50 organizations in life sciences, healthcare, government, academic medical centers, and research institutes to study...
SDOH factors like housing and financial stability are key to medication adherence
Social drivers of health (SDOH), such as increased financial struggles and decreased social support, have been shown to be correlated with decreased medication adherence. In this...
Truveta advances its commitment to security, privacy, and trust
Truveta today announced it has completed a Type 2 System and Organization Controls (SOC) 2 examination, which underscores Truveta’s commitments to security and trust. Type 2 SOC...
Trends in prescriptions following venous stent placement
The aim of this analysis was to compare different prescription trends post-venous stenting and set the foundation for future research. We identified a disparity showing that...
Variation in medication adherence for type 2 diabetes patients
Annually, over 125,000 deaths are associated with poor medication adherence. The proportion of days covered (PDC) is a common method to measure adherence. When controlling for...
De-risking clinical programs using data from EHRs: an example from medtech
In the realm of medtech innovation, the margin for error is slim. Upwards of 90% of funding for an early-stage company may be allocated to engineering and clinical costs, making...
Truveta recognized on LinkedIn Top Startups 2023 list
LinkedIn’s 7th annual Top Startups list – a ranking based on LinkedIn data of the top 50 emerging US companies – has some fresh new faces on it, including Truveta. The list is...
Advice from physicians as COVID and RSV cases begin to rise this fall
It’s only September, but COVID-19 and respiratory syncytial virus (RSV) cases are already rising. The latest Truveta Research monitoring report shows that for people over 65,...
Advancing epilepsy research: Insights from Truveta’s epilepsy data
Epilepsy is a complex neurological disorder, characterized by recurrent, unpredictable seizures. The fourth most common neurological disorder in the world, an estimated 3.4...